Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRK4 Polymorphisms and Candesartan Response in Hypertension
NCT01629225Phase 4Unknown
- Sponsor
- Army Medical University
- Start
- Jul 2013
- Primary completion
- Jul 2015
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of candesartan in essential hypertension, sponsored by Army Medical University. Status: unknown.
02
Drugs
candesartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01629225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01629225.